Treatment-associated decline in JAK2V617F allele burden in polycythemia vera: What does it mean?

被引：2
|
作者：
Tefferi, Ayalew [1 ]
Pardanani, Animesh [1 ]
Gangat, Naseema [1 ]
机构：
[1] Mayo Clin, Dept Med, Div Hematol, 200 First St SW, Rochester, MN 55905 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2024年 / 99卷 / 08期
关键词：
HYDROXYUREA; MUTATIONS; THERAPY; CALRETICULIN; RUXOLITINIB; JAK2(V617F); TRIAL; AGE;
D O I：
10.1002/ajh.27375
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1459 / 1461
页数：3
相关论文
共 50 条
  • [21] Influence of JAK2V617F allele burden on clinical phenotype of polycythemia vera patients: A study from India
    Sazawal, Sudha
    Singh, Kanwaljeet
    Chhikara, Sunita
    Chaubey, Rekha
    Mahapatra, Manoranjan
    Saxena, Renu
    SOUTH ASIAN JOURNAL OF CANCER, 2019, 8 (02) : 127 - 129
  • [22] Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden
    A M Vannucchi
    E Antonioli
    P Guglielmelli
    G Longo
    A Pancrazzi
    V Ponziani
    C Bogani
    P R Ferrini
    A Rambaldi
    V Guerini
    A Bosi
    T Barbui
    Leukemia, 2007, 21 : 1952 - 1959
  • [23] Consequences of the JAK2V617F allele burden for the prediction of transformation into myelofibrosis from polycythemia vera and essential thrombocythemia
    Shuichi Shirane
    Marito Araki
    Soji Morishita
    Yoko Edahiro
    Yoshitaka Sunami
    Yumi Hironaka
    Masaaki Noguchi
    Michiaki Koike
    Eriko Sato
    Akimichi Ohsaka
    Norio Komatsu
    International Journal of Hematology, 2015, 101 : 148 - 153
  • [24] The presence of JAK2V617F in primary myelofibrosis or its allele burden in polycythemia vera predicts chemosensitivity to hydroxyurea
    Sirhan, Shireen
    Lasho, Terra L.
    Hanson, Curtis A.
    Mesa, Ruben A.
    Pardanani, Animesh
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (05) : 363 - 365
  • [25] Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden
    Vannucchi, A. M.
    Antonioli, E.
    Guglielmelli, P.
    Longo, G.
    Pancrazzi, A.
    Ponziani, V.
    Bogani, C.
    Ferrini, P. Rossi
    Rambaldi, A.
    Guerini, V.
    Bosi, A.
    Barbui, T.
    LEUKEMIA, 2007, 21 (09) : 1952 - 1959
  • [26] The presence of the JAK2V617F mutation in primary myelofibrosis and its allele burden in polycythemia vera predict chemosensitivity to hydroxyurea
    Sirhan, Shireen
    Huang, Jocelin
    Li, Chin-Yang
    Tefferi, Ayalew
    BLOOD, 2007, 110 (11) : 1036A - 1036A
  • [27] Hematopoietic clonal dominance, stem cell mutations, and evolutionary pattern of JAK2V617F allele burden in polycythemia vera
    Angona, Anna
    Alvarez-Larran, Alberto
    Bellosillo, Beatriz
    Martinez-Aviles, Luz
    Camacho, Laura
    Fernandez-Rodriguez, Concepcion
    Pairet, Silvia
    Longaron, Raquel
    Ancochea, Agueda
    Senin, Alicia
    Florensa, Lourdes
    Besses, Carles
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (03) : 251 - 257
  • [28] A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera
    Furuya, Chiho
    Hashimoto, Yoshinori
    Morishita, Soji
    Fukuda, Yasutaka
    Inano, Tadaaki
    Ochiai, Tomonori
    Shirane, Shuichi
    Edahiro, Yoko
    Araki, Marito
    Ando, Miki
    Komatsu, Norio
    HEMATOLOGY, 2024, 29 (01)
  • [29] THE JAK2V617F MUTATION STATUS AND ALLELE BURDEN IN THAI PATIENTS WITH POLYCYTHEMIA VERA (PV) AND ESSENTIAL THROMBOCYTHEMIA (ET)
    Singdong, Roongrudee
    Siriboonpiputtana, Teerapong
    Kongruang, Adcharee
    Limsuwanachot, Nittaya
    Chareonsirisuthigul, Takol
    Chuncharunee, Suporn
    Sirirat, Tanasan
    Rerkamnuaychoke, Budsaba
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 98 - 98
  • [30] Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis
    Chen, Chih-Cheng
    Chen, Justin L.
    Lin, Alex Jia-Hong
    Yu, Lennex Hsueh-Lin
    Hou, Hsin-An
    ANNALS OF HEMATOLOGY, 2024, 103 (06) : 1947 - 1965
12345